Guidance for Applicants Preparing Applications for Summer 2022 Due Dates During the COVID-19 Pandemic

May 17, 2022

For applicants preparing applications for the summer 2022 due dates, NIH recently extended the guidance that while grant applications should not include contingency or recovery plans for problems resulting from the COVID-19 pandemic, investigators may address effects due to the pandemic on productivity or other scoreable issues in the personal statement of the biosketch.

Gearing Up for 2023 Part II: Implementing the NIH Data Management and Sharing Policy

May 12, 2022

I should note that when we started to receive comments on what was to become the NIH DMS Policy, one thing in particular stood out to us. Many commentors told us it would be helpful to have clear information on how to protect the privacy and respect the autonomy of participants when sharing data. Now, we all know that cliffhangers build anticipation, so without further delay, I want to share with you some of the tools NIH has been working on to answer that call.

NIH All About Grants Podcast: Building Bridges

May 12, 2022

Join us for this NIH All About Grants podcast episode to learn more about R56/bridge awards. Drs. Lakshmi Ramachandra from the National Institute of Allergy and Infectious Diseases and Bonnie Burgess-Beusse with the National Institute of Diabetes and Digestive and Kidney Diseases will tell us about the purpose of bridge awards, how program staff consider who and what to recommend for funding, the budget, when investigators should reach out about them, and more.

Congress Strengthens NIH’s Ability To Address Harassment in NIH-funded Activities

May 10, 2022

The recently passed Consolidated Appropriations Act for fiscal year 2022 includes “Section 239,” which is a milestone in our efforts to ensure safe working conditions for people engaged in NIH-supported research. The law requires NIH grant recipients to notify us when their senior key personnel are removed from their position or are otherwise disciplined due to concerns about harassment, bullying, retaliation, or hostile working conditions. This is a major step in our continued effort to change the culture of harassment in biomedical science.